236 related articles for article (PubMed ID: 1487164)
21. Serological aspects of coeliac disease.
Mascart-Lemone F; Van den Broeck J; Cadranel S; Colombel JF
Acta Gastroenterol Belg; 1992; 55(2):200-8. PubMed ID: 1632137
[TBL] [Abstract][Full Text] [Related]
22. [Relevance of anti-tissue transglutaminase antibodies in coeliac disease diagnosis].
Lepers S; Soula F; Fily S; Fontaine E; Vuye S; Colombel JF; Guimber D; Prin L; Dubucquoi S
Ann Biol Clin (Paris); 2003; 61(3):337-43. PubMed ID: 12805013
[TBL] [Abstract][Full Text] [Related]
23. IgA anti-tissue transglutaminase as a diagnostic marker of gluten sensitive enteropathy.
Lock RJ; Pitcher MC; Unsworth DJ
J Clin Pathol; 1999 Apr; 52(4):274-7. PubMed ID: 10474519
[TBL] [Abstract][Full Text] [Related]
24. Treatment of giardiasis reverses "active" coeliac disease to "latent" coeliac disease.
Carroccio A; Cavataio F; Montalto G; Paparo F; Troncone R; Iacono G
Eur J Gastroenterol Hepatol; 2001 Sep; 13(9):1101-5. PubMed ID: 11564963
[TBL] [Abstract][Full Text] [Related]
25. Serological markers and HLA genes among healthy first-degree relatives of patients with coeliac disease.
Mäki M; Holm K; Lipsanen V; Hällström O; Viander M; Collin P; Savilahti E; Koskimies S
Lancet; 1991 Nov; 338(8779):1350-3. PubMed ID: 1682735
[TBL] [Abstract][Full Text] [Related]
26. Anti-endomysium and anti-gliadin antibodies as serological markers for coeliac disease in childhood: a clinical study to develop a practical routine.
Grodzinsky E; Jansson G; Skogh T; Stenhammar L; Fälth-Magnusson K
Acta Paediatr; 1995 Mar; 84(3):294-8. PubMed ID: 7780251
[TBL] [Abstract][Full Text] [Related]
27. Endomysial antibody-negative coeliac disease: clinical characteristics and intestinal autoantibody deposits.
Salmi TT; Collin P; Korponay-Szabó IR; Laurila K; Partanen J; Huhtala H; Király R; Lorand L; Reunala T; Mäki M; Kaukinen K
Gut; 2006 Dec; 55(12):1746-53. PubMed ID: 16571636
[TBL] [Abstract][Full Text] [Related]
28. Follow-up of patients positive in reticulin and gliadin antibody tests with normal small-bowel biopsy findings.
Collin P; Helin H; Mäki M; Hällström O; Karvonen AL
Scand J Gastroenterol; 1993 Jul; 28(7):595-8. PubMed ID: 8362211
[TBL] [Abstract][Full Text] [Related]
29. Prevalence of coeliac disease in diabetic children and adolescents in Sweden.
Sigurs N; Johansson C; Elfstrand PO; Viander M; Lanner A
Acta Paediatr; 1993 Sep; 82(9):748-51. PubMed ID: 8241671
[TBL] [Abstract][Full Text] [Related]
30. Serological markers identify histologically latent coeliac disease among first-degree relatives.
Vazquez H; Cabanne A; Sugai E; Fiorini A; Pedreira S; Mauriño E; Smecuol E; Dezi R; Niveloni S; Valero J; De Rosa S; Litwin N; Kogan Z; Boerr LA; Bai JC
Eur J Gastroenterol Hepatol; 1996 Jan; 8(1):15-21. PubMed ID: 8900904
[TBL] [Abstract][Full Text] [Related]
31. Antibodies in relation to gluten intake.
Mäki M; Sulkanen S; Collin P
Dig Dis; 1998; 16(6):330-2. PubMed ID: 10207216
[TBL] [Abstract][Full Text] [Related]
32. Atypical coeliac disease found with serologic screening.
Collin P; Hällström O; Mäki M; Viander M; Keyriläinen O
Scand J Gastroenterol; 1990 Mar; 25(3):245-50. PubMed ID: 2320942
[TBL] [Abstract][Full Text] [Related]
33. Genetic, morphometric and immunohistochemical markers of latent coeliac disease.
Johnston SD; Watson RG; Middleton D; McMillan SA; Maxwell P; Hamilton P; Love AH
Eur J Gastroenterol Hepatol; 1999 Nov; 11(11):1283-8. PubMed ID: 10563541
[TBL] [Abstract][Full Text] [Related]
34. Factors associated with serum antibodies to reticulin, endomysium, and gliadin in an adult population.
McMillan SA; Watson RP; McCrum EE; Evans AE
Gut; 1996 Jul; 39(1):43-7. PubMed ID: 8881807
[TBL] [Abstract][Full Text] [Related]
35. Transthyretin values correlate with mucosal recovery in patients with coeliac disease taking a gluten free diet.
McMillan SA; Dickey W; Douglas JP; Hughes DF
J Clin Pathol; 2001 Oct; 54(10):783-6. PubMed ID: 11577127
[TBL] [Abstract][Full Text] [Related]
36. Autoimmune enteropathy and villous atrophy in adults.
Corazza GR; Biagi F; Volta U; Andreani ML; De Franceschi L; Gasbarrini G
Lancet; 1997 Jul; 350(9071):106-9. PubMed ID: 9228963
[TBL] [Abstract][Full Text] [Related]
37. Reliance on serum endomysial antibody testing underestimates the true prevalence of coeliac disease by one fifth.
Dickey W; Hughes DF; McMillan SA
Scand J Gastroenterol; 2000 Feb; 35(2):181-3. PubMed ID: 10720117
[TBL] [Abstract][Full Text] [Related]
38. [Antigliadin, antireticulin, antiendomysium antibodies: value in the diagnosis and follow-up of celiac disease in children].
Olives JP; Baudon JJ; Dabadie A; Fontaine JL; Lamireau T; Morali A; Rieu D; Sarles J; Schmitz J; Touhami M
Arch Pediatr; 1994 Feb; 1(2):181-5. PubMed ID: 7987448
[TBL] [Abstract][Full Text] [Related]
39. In vivo targeting of intestinal and extraintestinal transglutaminase 2 by coeliac autoantibodies.
Korponay-Szabó IR; Halttunen T; Szalai Z; Laurila K; Király R; Kovács JB; Fésüs L; Mäki M
Gut; 2004 May; 53(5):641-8. PubMed ID: 15082580
[TBL] [Abstract][Full Text] [Related]
40. Endomysial antibody production is not related to histological damage after in vitro gluten challenge.
Biagi F; Parnell ND; Ellis HJ; Ciclitira PJ
Eur J Gastroenterol Hepatol; 2000 Jan; 12(1):57-60. PubMed ID: 10656211
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
